Dr. Jeffrey R. Jay, M.D. »

Rapt Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2025-12-31 $20M 581k 33.87

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Amylyx Pharmaceuticals (AMLX)
Zura Bio Class A Ord Shs (ZURA)
Disc Medicine (IRON)
Rapt Therapeutics Com New (RAPT)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Vor Biopharma Com New (VOR)
Dianthus Therapeutics (DNTH)
Jade Biosciences Com New (JBIO)
Kalvista Pharmaceuticals (KALV)
Contineum Therapeutics Cl A (CTNM)
Eupraxia Pharmaceuticals (EPRX)
Fulcrum Therapeutics (FULC)
Nektar Therapeutics Com New (NKTR)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Rapt Therapeutics

Rtw Investments
TCG Crossover Management
Foresite Capital Management VI
Vanguard Group
OrbiMed Advisors
Ikarian Capital
Braidwell
Boone Capital Management
Nantahala Capital Management
Deep Track Capital
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.
Siren
Redmile Group

View all funds holding Rapt Therapeutics